DAFNA Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

DAFNA Capital Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,000	Closed	-$590K	–	82
2022 Q4	$590K	Buy	+48,000	New	+$1.14M	0.17%	60

DAFNA Capital Management's CINC Position: Q1 2023 in Review

DAFNA Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 48,000 shares — an estimated $590K sold.

DAFNA Capital Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $590K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

DAFNA Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
DAFNA Capital Management sold 48,000 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $590K.
DAFNA Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
DAFNA Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $590K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on DAFNA Capital Management's 13F filing for Q1 2023, filed 15 May 2023.